AVANOS MEDICAL, INC.
AVANOS MEDICAL, INC.
ALPHARETTA, GA
Loading...
Price History
Market Data
| Market Cap | 1.15B |
| P/E Ratio | - |
| P/B Ratio | 1.48 |
| EPS | -1.57 |
| Dividend Yield | - |
| D/E Ratio | 0.38 |
| Current Ratio | 2.15 |
| Currency | USD |
Key Financial Metrics
701.20M
Revenue
-72.90M
Net Income
-1.57
EPS (Diluted)
76.90M
Free Cash Flow
Profitability
Gross Margin
50.5%
Operating Margin
-8.8%
Net Profit Margin
-10.4%
EBITDA
6.50M
Returns & Efficiency
Return on Assets (ROA)
-6.8%
Return on Equity (ROE)
-9.4%
Dividend Yield
-
EPS
-1.57
Financial Health
Total Assets
1.07B
Total Debt
90.30M
Debt to Equity
0.38x
Current Ratio
2.15
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | ALPHARETTA, GA |
| Fiscal Year | 2025 |
Peers
159.78B
P/E: --
47.89B
P/E: --
STERIS PLC
STE
20.92B
P/E: --
16.05B
P/E: --
16.05B
P/E: --
ALIGN TECHNOLOGY INC
ALGN
12.12B
P/E: --
6.92B
P/E: --
MSA SAFETY INC
MNESP
6.92B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.15B
P/E Ratio (TTM)-
Price to Book1.48
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin50.5%
Operating Margin-8.8%
Net Margin-10.4%
ROE-9.4%
ROA-6.8%
Leverage & Liquidity
Debt to Equity0.38
Current Ratio2.15
Total Debt$90.30M
Total Assets$1.07B
Stockholders' Equity$778.20M
Income Statement (FY 2025)
Revenue$701.20M
Gross Profit$353.90M
Operating Income$-61.60M
Net Income$-72.90M
EPS (Diluted)$-1.57
Cash Flow (FY 2025)
Free Cash Flow$76.90M
Cash & Equivalents$89.80M
Revenue Growth1.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 5405 WINDWARD PARKWAY SUITE 100 SOUTH ALPHARETTA, GA 30004 |
| Phone | 844-428-2667 |
| Incorporated | DE, US |
| EIN | 464987888 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 46.50M |
| Stockholders' Equity | $778.20M |
| Cash & Equivalents | $89.80M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-05
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-14
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-14
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-14
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | AVANOS MEDICAL, INC. |
| Ticker | AVNS |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | ALPHARETTA, GA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.15B |
| Revenue | 701.20M |
| Net Income | -72.90M |
| P/E Ratio | - |
| EPS | -1.57 |
| Net Margin | -10.4% |
| ROE | -9.4% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...